The global regulatory environment for oncology therapies is undergoing a major transformation, profoundly influencing the commercial strategies of firms within the Colorectal Cancer Drugs Market. Recognizing the urgent public health need for advanced cancer solutions, major regulatory bodies are increasingly utilizing specialized expedited pathways, such as Breakthrough Therapy designations and...